Clinical Study results promising for CCT product
Results from a clinical study provide promising feasibility indications for Brain+’ CCT technology for cognitive training A study conducted by Nottingham University as part of the Brain+ led European Horizon2020 project called Alzheimer’s Detect & […]
Brain+ first municipal sale of its new dementia product
Brain+ closes 2022 with the first municipal sale of its new dementia product and begins the monetization journey Another milestone has been met by Brain+ as it closes the year with the first sale of […]
3-Year Innovation Project is Completed
3-year innovation project with the Danish Life Science Cluster is completed with the Brain+ CST-Therapist Companion product as the final output A 3-year collaboration project between VIA University College, MedTech Innovation Consortium (MTIC), and Brain+ […]
Strong Q4 with Product Launch & Successful Capital Raise
Brain+ announces Investor Webinar following strong Q4 with product launch and succesful capital raise Brain+ invites you to an investor webinar after a strong quarter with commercial introduction of its first dementia product, a successful […]
Pilot with volunteers from DaneAge Association
Brain+ begins commercial pilot with volunteers from the DaneAge Association Brain+, a pioneer in the development of digital therapeutics for Alzheimer’s disease, is excited to announce the launch of a pilot project with DaneAge (Ældre Sagen) […]
Implementation of an ISO 13485 for Medical Devices
Brain+ completes the implementation of an ISO 13485 Quality Management System for Medical Devices Brain+ has successfully completed the implementation of an ISO 13485-compliant Quality Management System (QMS). Such a system helps to set standards […]
WHO points to CST to solve the dementia burden
A new WHO report points to Cognitive Stimulation Therapy (CST) and digital solutions As means to help solve the global dementia burden The World Health Organization (WHO) recently published a large report, A blueprint For Dementia […]
Leading dementia researcher joins Brain+
Brain+ adds new clinical and development competences To accelerate and support market access of its digital dementia product portfolio Brain+ (BRAINP), a pioneer in the development of digital therapeutics for Alzheimer’s disease and dementia, has […]
First milestone met
Brain+ meets milestone with Rox Health (Roche Germany) October 11, 2022 – Brain+, a pioneer in the development of digital therapeutics for Alzheimer’s disease and dementia, has met the first of three milestones in its […]
Accelerated launch Q2 2023
Brain+ partners with German medical distributor Advances launch of its first CST dementia product in Germany to Q2 2023 Through Coopmed, Brain+ will be represented by experienced and local medical sales managers in Germany […]